Reckitt Benckiser Sheds Nearly $7 Billion in Market Value After Infant-Formula Verdict — Update
By Michael Susin
Reckitt Benckiser lost almost $7 billion in market value after a jury in an Illinois court sided with a plaintiff in a case relating to its Enfamil infant formula.
London-listed shares in the U.K. consumer-goods company closed nearly 15% lower at GBP44.86 on Friday, according to FactSet, giving the group a market value of almost GBP31.95 billion ($40.74 billion).
The rout came after it was reported that an Illinois jury ordered the company's infant-formula unit, Mead Johnson, to pay $60 million in compensation related to the death of a premature baby who was fed Enfamil.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said Friday that it strongly disagrees with the jury's decision to fault Mead Johnson and that it doesn't believe any of its products cause necrotizing enterocolitis, a life-threatening gastrointestinal disease.
"We will pursue all options to overturn the verdict," it said, adding that the allegations from the plaintiff weren't supported by the science.
Mead Johnson Nutrition Company was acquired by Reckitt in June 2017.
"Based on the size of this fine, the share move is massively overstating the initial impact, which suggests investors are preparing for more to come," Hargreaves Lansdown head of money and markets, Susannah Streeter, said in market comment.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
March 15, 2024 14:03 ET (18:03 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
The Best Bank Stocks to Buy
-
After Earnings, Is Roblox Stock a Buy, Sell, or Fairly Valued?
-
Should You Buy and Hold an Artificial Intelligence Portfolio?
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains